As of 2024-12-11, the Fair Value of Rubius Therapeutics Inc (RUBY) is -14.47 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 USD, the upside of Rubius Therapeutics Inc is -17,533.68%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -89.20 | -163.46 | -167.73 | -196.55 | -179.67 | -159.32 |
| YoY growth | -103.42% | -83.25% | -2.61% | -17.18% | 8.59% | -39.58% |
| Market Cap (mil) | 5.15 |
| P/E | |
| Forward P/E | -x |
| EPS | -2.89 |
| Avg earnings growth rate | -39.58% |
| TTM earnings | -179.66 |